Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study.
Morris C, Iacobelli S, Brand R, Bjorkstrand B, Drake M, Niederwieser D, Gahrton G; Chronic Leukaemia Working Party Myeloma Subcommittee, European Group for Blood and Marrow Transplantation. Morris C, et al. Among authors: bjorkstrand b. J Clin Oncol. 2004 May 1;22(9):1674-81. doi: 10.1200/JCO.2004.06.144. Epub 2004 Mar 22. J Clin Oncol. 2004. PMID: 15037597
Primary plasma cell leukemia and autologous stem cell transplantation.
Drake MB, Iacobelli S, van Biezen A, Morris C, Apperley JF, Niederwieser D, Björkstrand B, Gahrton G; European Group for Blood and Marrow Transplantation and the European Leukemia Net. Drake MB, et al. Among authors: bjorkstrand b. Haematologica. 2010 May;95(5):804-9. doi: 10.3324/haematol.2009.013334. Haematologica. 2010. PMID: 20442444 Free PMC article.
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Björkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Musto P, Beksac M, Bosi A, Milone G, Corradini P, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Gahrton G. Björkstrand B, et al. J Clin Oncol. 2011 Aug 1;29(22):3016-22. doi: 10.1200/JCO.2010.32.7312. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730266
Efficacy and outcome of autologous transplantation in rare myelomas.
Morris C, Drake M, Apperley J, Iacobelli S, van Biezen A, Bjorkstrand B, Goldschmidt H, Harousseau JL, Morgan G, de Witte T, Niederwieser D, Gahrton G; Myeloma Subcommittee of Chronic Leukaemia Working Party of EBMT. Morris C, et al. Among authors: bjorkstrand b. Haematologica. 2010 Dec;95(12):2126-33. doi: 10.3324/haematol.2010.022848. Epub 2010 Oct 22. Haematologica. 2010. PMID: 20971818 Free PMC article.
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
Crawley C, Lalancette M, Szydlo R, Gilleece M, Peggs K, Mackinnon S, Juliusson G, Ahlberg L, Nagler A, Shimoni A, Sureda A, Boiron JM, Einsele H, Chopra R, Carella A, Cavenagh J, Gratwohl A, Garban F, Zander A, Björkstrand B, Niederwieser D, Gahrton G, Apperley JF; Chromic Leukaemia Working Party of the EBMT. Crawley C, et al. Among authors: bjorkstrand b. Blood. 2005 Jun 1;105(11):4532-9. doi: 10.1182/blood-2004-06-2387. Epub 2005 Feb 24. Blood. 2005. PMID: 15731182 Free article.
High-dose treatment of multiple myeloma.
Gahrton G, Björkstrand B. Gahrton G, et al. Among authors: bjorkstrand b. Crit Rev Oncol Hematol. 1999 Apr;30(2):173-80. doi: 10.1016/s1040-8428(98)00052-3. Crit Rev Oncol Hematol. 1999. PMID: 10439061 Review. No abstract available.
Role of stem cell transplantation in myeloma.
Gahrton G, Iacobelli S, Björkstrand B, Bourhis J, Corradini P, Crawley C, Morris C, Niederwieser D; European Group for Blood and Marrow Transplantation. Gahrton G, et al. Among authors: bjorkstrand b. Hematology. 2005;10 Suppl 1:127-8. doi: 10.1080/10245330512331390168. Hematology. 2005. PMID: 16276618 Review. No abstract available.
67 results